XML 48 R36.htm IDEA: XBRL DOCUMENT
v3.25.3

Stock Compensation and Earnings (Loss) per Share (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2025
Share-Based Payment Arrangement [Abstract] |
Schedule of restricted stock shares activity | Activity related to the Company’s equity compensation, which includes the Company’s restricted stock units (“RSUs”) and performance stock units (“PSUs”), was as follows:
(in thousands, except weighted average grant price) | Number of Shares |  | Weighted Average Grant Price
Outstanding awards, December 31, 2024 | 875 |  |  | $ | 20.63 |
Granted | 756 |  |  | 12.06 |
Vested | (345) |  |  | 20.70 |
Forfeited | (50) |  |  | 16.60 |
Outstanding awards, September 30, 2025 | 1,236 |  |  | 15.53 |
Activity related to the Company’s Relative Total Shareholder Return RSUs (“RTSRs”) was as follows:
(in thousands, except weighted average grant price) | Number of Shares |  | Weighted Average Grant Price
Outstanding awards, December 31, 2024 | 259 |  |  | $ | 22.96 |
Granted | 246 |  |  | 12.31 |
Vested | — |  |  | — |
Forfeited | (22) |  |  | 18.06 |
Outstanding awards, September 30, 2025 | 483 |  |  | 17.76 |
Schedule of stock compensation expense | Stock-based compensation expense was as follows:
| Three Months Ended September 30, |  | Nine Months Ended September 30,
(in thousands) | 2025 |  | 2024 |  | 2025 |  | 2024
Stock compensation expense | $ | 2,260 |  |  | $ | 1,566 |  |  | $ | 8,650 |  |  | $ | 8,239 |
Capitalized stock compensation | (194) |  |  | (182) |  |  | (680) |  |  | (619) |
Stock compensation expense, net | $ | 2,066 |  |  | $ | 1,384 |  |  | $ | 7,970 |  |  | $ | 7,620 |
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share | The following table indicates the computation of basic and diluted earnings (loss) per share:
| Three Months Ended September 30, |  | Nine Months Ended September 30,
(in thousands, except per share amounts) | 2025 |  | 2024 |  | 2025 |  | 2024
Calculation of net (loss) income per share: |  |  |  |  |  |  |
Loss from continuing operations | $ | (9,390) |  |  | $ | (5,304) |  |  | $ | (27,570) |  |  | $ | (22,167) |
Total income from discontinued operations, net of tax | — |  |  | 41 |  |  | — |  |  | 218,728 |
Net (loss) income | $ | (9,390) |  |  | $ | (5,263) |  |  | $ | (27,570) |  |  | $ | 196,561 |
Amounts attributable to common shareholders |  |  |  |  |  |  |
Loss from continuing operations | $ | (10,913) |  |  | $ | (6,942) |  |  | $ | (32,062) |  |  | $ | (23,805) |
Total income from discontinued operations | — |  |  | 41 |  |  | — |  |  | 218,728 |
Net (loss) income attributable to common shareholders | $ | (10,913) |  |  | $ | (6,901) |  |  | $ | (32,062) |  |  | $ | 194,923 |
Basic and diluted weighted average shares outstanding | 55,150 |  |  | 54,781 |  |  | 55,083 |  |  | 53,370 |
Per share amounts attributable to common shareholders |  |  |  |  |  |  |
Loss from continuing operations | $ | (0.20) |  |  | $ | (0.13) |  |  | $ | (0.58) |  |  | $ | (0.45) |
Income from discontinued operations, net of tax | — |  |  | — |  |  | — |  |  | 4.10 |
Net (loss) income per share | $ | (0.20) |  |  | $ | (0.13) |  |  | $ | (0.58) |  |  | $ | 3.65 |
The following table presents potentially dilutive instruments:
| Three Months Ended September 30, |  | Nine Months Ended September 30,
(in thousands) | 2025 |  | 2024 |  | 2025 |  | 2024
Potentially dilutive equity awards | 664 |  |  | 423 |  |  | 468 |  |  | 373 |
Potentially dilutive shares related to the Series A Preferred Stock | 3,615 |  |  | 3,373 |  |  | 3,615 |  |  | 3,373 |
Total potentially dilutive instruments | 4,279 |  |  | 3,796 |  |  | 4,083 |  |  | 3,746 |

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration